Lupin
Girish Vyas is a finance professional with extensive experience across multiple leadership roles in financial management. Currently serving as Deputy General Manager of Finance at Lupin since May 2017, Vyas leads the business finance function of the Biosimilar unit, focusing on financial project management and cost-benefit analysis. Prior experience includes a tenure as Senior Manager at Essar Investments Limited from July 2009 to April 2017, overseeing the finance function for 15 group companies, and a role as Audit Manager at Nisar & Kumar on deputation to the Essar group. Additionally, Vyas has held positions as Deputy Manager at BSE Institute Ltd, managing Futures and Options operations, and as an Article Trainee at P.D. Saraf & Co, completing statutory and tax audits. Vyas holds a Chartered Accountant designation from The Institute of Chartered Accountants of India and a Master's degree in Business Analytics from NMIMS CDOE.
This person is not in any teams
This person is not in any offices
Lupin
15 followers
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments.